Increasing cases of microcephaly and Guillain-Barre syndrome apparently associated with Zika virus disease have led WHO to declare the current outbreak in Latin America a public health emergency of international concern.There are no existing medical countermeasures to prevent or treat Zika on the market today, and many diagnostic tests are still in the early stages of development.
Of those diagnostic tests commercially available, very few have undergone regulatory premarket assessment. Quality-assured, safe and effective diagnostics are therefore a top priority in our medical response.
In addition, these tests will need to be able to identify individuals infected with Zika virus as opposed to other diseases with similar symptoms caused by